Current hematologic malignancy reports

Keyphrases

Publications

2024

Tariq Kewan, Maximillian Stahl, Jan Philipp Bewersdorf, Amer M Zeidan
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities. Current hematologic malignancy reports (2024)
Tariq Kewan, Maximillian Stahl, Jan Philipp Bewersdorf, Amer M Zeidan
Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities. Current hematologic malignancy reports (2024)

volume 19, number 2, 2024

Richard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, Armin Shahrokni, Ann A Jakubowski, Sergio A Giralt
Transplantation and Cellular Therapy for Older Adults-The MSK Approach. Current hematologic malignancy reports 19 (2) (2024)
Fatima Warsame, Douglas A Simonetto
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations. Current hematologic malignancy reports 19 (2) (2024)
Richard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, Armin Shahrokni, Ann A Jakubowski, Sergio A Giralt
Transplantation and Cellular Therapy for Older Adults-The MSK Approach. Current hematologic malignancy reports 19 (2) (2024)
Richard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, Armin Shahrokni, Ann A Jakubowski, Sergio A Giralt
Transplantation and Cellular Therapy for Older Adults-The MSK Approach. Current hematologic malignancy reports 19 (2) (2024)
Richard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, Armin Shahrokni, Ann A Jakubowski, Sergio A Giralt
Transplantation and Cellular Therapy for Older Adults-The MSK Approach. Current hematologic malignancy reports 19 (2) (2024)
Amneet Bajwa, Alma Habib, Adam S Kittai
Treatment of Richter's Transformation with Novel Therapies. Current hematologic malignancy reports 19 (2) (2024)
Catherine C Coombs
Frontline Therapy of CLL-Changing Treatment Paradigms. Current hematologic malignancy reports 19 (2) (2024)
Catherine C Coombs
Frontline Therapy of CLL-Changing Treatment Paradigms. Current hematologic malignancy reports 19 (2) (2024)
Amneet Bajwa, Alma Habib, Adam S Kittai
Treatment of Richter's Transformation with Novel Therapies. Current hematologic malignancy reports 19 (2) (2024)
Parathan Karunakaran, Nidhi Jain, Deepesh P Lad
How Do We Manage Chronic Lymphocytic Leukemia in India. Current hematologic malignancy reports 19 (2) (2024)
Amneet Bajwa, Alma Habib, Adam S Kittai
Treatment of Richter's Transformation with Novel Therapies. Current hematologic malignancy reports 19 (2) (2024)
Richard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, Armin Shahrokni, Ann A Jakubowski, Sergio A Giralt
Transplantation and Cellular Therapy for Older Adults-The MSK Approach. Current hematologic malignancy reports 19 (2) (2024)
Fatima Warsame, Douglas A Simonetto
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations. Current hematologic malignancy reports 19 (2) (2024)
Richard J Lin, Parastoo B Dahi, Beatriz Korc-Grodzicki, Armin Shahrokni, Ann A Jakubowski, Sergio A Giralt
Transplantation and Cellular Therapy for Older Adults-The MSK Approach. Current hematologic malignancy reports 19 (2) (2024)
Catherine C Coombs
Frontline Therapy of CLL-Changing Treatment Paradigms. Current hematologic malignancy reports 19 (2) (2024)
Parathan Karunakaran, Nidhi Jain, Deepesh P Lad
How Do We Manage Chronic Lymphocytic Leukemia in India. Current hematologic malignancy reports 19 (2) (2024)
Amneet Bajwa, Alma Habib, Adam S Kittai
Treatment of Richter's Transformation with Novel Therapies. Current hematologic malignancy reports 19 (2) (2024)
Parathan Karunakaran, Nidhi Jain, Deepesh P Lad
How Do We Manage Chronic Lymphocytic Leukemia in India. Current hematologic malignancy reports 19 (2) (2024)
Fatima Warsame, Douglas A Simonetto
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations. Current hematologic malignancy reports 19 (2) (2024)

volume 19, number 3, 2024

Delphine Rea, Sofiane Fodil, Etienne Lengline, Emmanuel Raffoux, Jean-Michel Cayuela
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions. Current hematologic malignancy reports 19 (3) (2024)
Prithviraj Bose
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices. Current hematologic malignancy reports 19 (3) (2024)
Prithviraj Bose
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices. Current hematologic malignancy reports 19 (3) (2024)
Prithviraj Bose
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices. Current hematologic malignancy reports 19 (3) (2024)
Tariq Kewan, Maximillian Stahl, Jan Philipp Bewersdorf, Amer M Zeidan
Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities. Current hematologic malignancy reports 19 (3) (2024)
Jane J Chen, Franco Castillo Tokumori, Christina Del Guzzo, Jeanyoung Kim, Jia Ruan
Update on T-Cell Lymphoma Epidemiology. Current hematologic malignancy reports 19 (3) (2024)
Delphine Rea, Sofiane Fodil, Etienne Lengline, Emmanuel Raffoux, Jean-Michel Cayuela
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions. Current hematologic malignancy reports 19 (3) (2024)
Delphine Rea, Sofiane Fodil, Etienne Lengline, Emmanuel Raffoux, Jean-Michel Cayuela
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions. Current hematologic malignancy reports 19 (3) (2024)
Reema K Tawfiq, Jithma P Abeykoon, Prashant Kapoor
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia. Current hematologic malignancy reports 19 (3) (2024)
Reema K Tawfiq, Jithma P Abeykoon, Prashant Kapoor
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia. Current hematologic malignancy reports 19 (3) (2024)
Jane J Chen, Franco Castillo Tokumori, Christina Del Guzzo, Jeanyoung Kim, Jia Ruan
Update on T-Cell Lymphoma Epidemiology. Current hematologic malignancy reports 19 (3) (2024)
Jane J Chen, Franco Castillo Tokumori, Christina Del Guzzo, Jeanyoung Kim, Jia Ruan
Update on T-Cell Lymphoma Epidemiology. Current hematologic malignancy reports 19 (3) (2024)
Reema K Tawfiq, Jithma P Abeykoon, Prashant Kapoor
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia. Current hematologic malignancy reports 19 (3) (2024)
Prithviraj Bose
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices. Current hematologic malignancy reports 19 (3) (2024)
Tariq Kewan, Maximillian Stahl, Jan Philipp Bewersdorf, Amer M Zeidan
Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities. Current hematologic malignancy reports 19 (3) (2024)
Tariq Kewan, Maximillian Stahl, Jan Philipp Bewersdorf, Amer M Zeidan
Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities. Current hematologic malignancy reports 19 (3) (2024)
Prithviraj Bose
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices. Current hematologic malignancy reports 19 (3) (2024)

volume 19, number 4, 2024

Valerie Tran, Kiarash Salafian, Kenan Michaels, Caroline Jones, Daniel Reed, Michael Keng, Firas El Chaer
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. Current hematologic malignancy reports 19 (4) (2024)
Hoda Pourhassan, Lindsey Murphy, Ibrahim Aldoss
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection. Current hematologic malignancy reports 19 (4) (2024)
Hoda Pourhassan, Lindsey Murphy, Ibrahim Aldoss
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection. Current hematologic malignancy reports 19 (4) (2024)
Valerie Tran, Kiarash Salafian, Kenan Michaels, Caroline Jones, Daniel Reed, Michael Keng, Firas El Chaer
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. Current hematologic malignancy reports 19 (4) (2024)
Valerie Tran, Kiarash Salafian, Kenan Michaels, Caroline Jones, Daniel Reed, Michael Keng, Firas El Chaer
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. Current hematologic malignancy reports 19 (4) (2024)
Karan L Chohan, Prashant Kapoor
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia. Current hematologic malignancy reports 19 (4) (2024)
Hoda Pourhassan, Lindsey Murphy, Ibrahim Aldoss
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection. Current hematologic malignancy reports 19 (4) (2024)
Valerie Tran, Kiarash Salafian, Kenan Michaels, Caroline Jones, Daniel Reed, Michael Keng, Firas El Chaer
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. Current hematologic malignancy reports 19 (4) (2024)
Karan L Chohan, Prashant Kapoor
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia. Current hematologic malignancy reports 19 (4) (2024)
Hoda Pourhassan, Lindsey Murphy, Ibrahim Aldoss
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection. Current hematologic malignancy reports 19 (4) (2024)
Rachel S Werk, Mallorie B Heneghan, Sherif M Badawy
Use of Patient-Centered Technology and Digital Interventions in Pediatric and Adult Patients with Hematologic Malignancies. Current hematologic malignancy reports 19 (4) (2024)
Rachel S Werk, Mallorie B Heneghan, Sherif M Badawy
Use of Patient-Centered Technology and Digital Interventions in Pediatric and Adult Patients with Hematologic Malignancies. Current hematologic malignancy reports 19 (4) (2024)